Page last updated: 2024-08-17

carbostyril and Neuroleptic Malignant Syndrome

carbostyril has been researched along with Neuroleptic Malignant Syndrome in 25 studies

Research

Studies (25)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	17 (68.00)	29.6817
2010's	8 (32.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Fraile, S; García, B; Hidalgo, FJ; Lopez, E	1
Chang, CH; Chang, YC; Chen, YW; Cheng, YS; Chung, W; Tseng, PT; Wang, HY; Wu, CK	1
Croarkin, PE; Emslie, GJ; Mayes, TL	1
Coffey, BJ; Groff, K	1
Marshall, PB; Mellman, TA; Nguyen, SX	1
Bledowski, J; Kahn, DA; Pandurangi, A; Trutia, A	1
Hauser, D; Ladds, B; Mejia, C; Thomas, P	1
Dassa, D; Drai-Moog, D; Samuelian, JC	1
Conley, Y; Davies, MA; Roth, BL	1
Brunetti, L; Patel, MK	1
Abler, B; Gahr, M; Orth, M	1
Chang, JP; Chen, YT; Su, KP	1
Anttila, E; Lahti, A; Räsänen, P; Riala, K	1
Chakraborty, N; Johnston, T	1
Alessi, NE; Radwan, K; Spalding, S	1
Duggal, HS; Kithas, J	1
Bourgeois, JA; Sanchez, R; Srephichit, S	1
Strawn, JR	1
Caroff, SN; Hammerman, S; Lam, C	1
Ali, S; Patel, P; Pearlman, RL; Upadhyay, A	1
Coffey, B; Jummani, R; Vito, J	1
Kang, SG; Kim, L; Lee, HJ; Lee, MS; Park, JS	1
Brunelle, J; Gouin, P; Guigueno, S; Tamion, F; Thibaut, F	1
Alici-Evcimen, Y; Basil, B; Evcimen, H; Gorman, JM; Mania, I; Mathews, M	1

Reviews

2 review(s) available for carbostyril and Neuroleptic Malignant Syndrome

Article	Year
Atypical neuroleptic malignant syndrome in patients treated with aripiprazole and clozapine: a case-series study and short review. International journal of psychiatry in medicine, 2015, Volume: 49, Issue:1 Topics: Adult; Aripiprazole; Clozapine; Creatine Kinase; Dose-Response Relationship, Drug; Drug Substitution; Drug Therapy, Combination; Female; Fluoxetine; Hospitalization; Humans; Injections, Intramuscular; Male; Middle Aged; Neuroleptic Malignant Syndrome; Piperazines; Psychotic Disorders; Quinolones; Schizophrenia; Schizophrenic Psychology	2015
Neuroleptic malignant syndrome associated with atypical antipsychotics in pediatric patients: a review of published cases. The Journal of clinical psychiatry, 2008, Volume: 69, Issue:7 Topics: Adolescent; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Bipolar Disorder; Child; Child, Preschool; Clozapine; Dibenzothiazepines; Humans; Neuroleptic Malignant Syndrome; Olanzapine; Piperazines; Quetiapine Fumarate; Quinolones; Retrospective Studies; Risperidone; Thiazoles	2008

Article

Year

Atypical neuroleptic malignant syndrome in patients treated with aripiprazole and clozapine: a case-series study and short review.

International journal of psychiatry in medicine, 2015, Volume: 49, Issue:1

Topics: Adult; Aripiprazole; Clozapine; Creatine Kinase; Dose-Response Relationship, Drug; Drug Substitution; Drug Therapy, Combination; Female; Fluoxetine; Hospitalization; Humans; Injections, Intramuscular; Male; Middle Aged; Neuroleptic Malignant Syndrome; Piperazines; Psychotic Disorders; Quinolones; Schizophrenia; Schizophrenic Psychology

2015

Neuroleptic malignant syndrome associated with atypical antipsychotics in pediatric patients: a review of published cases.

The Journal of clinical psychiatry, 2008, Volume: 69, Issue:7

Topics: Adolescent; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Bipolar Disorder; Child; Child, Preschool; Clozapine; Dibenzothiazepines; Humans; Neuroleptic Malignant Syndrome; Olanzapine; Piperazines; Quetiapine Fumarate; Quinolones; Retrospective Studies; Risperidone; Thiazoles

2008

Other Studies

23 other study(ies) available for carbostyril and Neuroleptic Malignant Syndrome

Article	Year
[Possible malignant neuroleptic syndrome associated with aripiprazole and imipramine and treated with bromocriptine]. Medicina clinica, 2013, Sep-21, Volume: 141, Issue:6 Topics: Antipsychotic Agents; Aripiprazole; Bromocriptine; Combined Modality Therapy; Drug Therapy, Combination; Emergencies; Frontotemporal Dementia; Humans; Imipramine; Lorazepam; Male; Mental Disorders; Middle Aged; Neuroleptic Malignant Syndrome; Oxygen Inhalation Therapy; Piperazines; Quinolones; Respiration, Artificial; Respiratory Insufficiency	2013
Psychosis or atypical neuroleptic malignant syndrome in an adolescent? Journal of child and adolescent psychopharmacology, 2008, Volume: 18, Issue:5 Topics: Adolescent; Antipsychotic Agents; Aripiprazole; Diagnosis, Differential; Humans; Male; Neuroleptic Malignant Syndrome; Piperazines; Psychotic Disorders; Quinolones	2008
Neuroleptic malignant syndrome with the addition of aripiprazole to olanzapine. The American journal of psychiatry, 2008, Volume: 165, Issue:11 Topics: Adult; Aggression; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Benztropine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Humans; Intellectual Disability; Male; Neuroleptic Malignant Syndrome; Neurologic Examination; Olanzapine; Piperazines; Quinolones; Risk Factors	2008
Neuroleptic rechallenge with aripiprazole in a patient with previously documented neuroleptic malignant syndrome. Journal of psychiatric practice, 2008, Volume: 14, Issue:6 Topics: Adult; Antipsychotic Agents; Aripiprazole; Creatine Kinase; Documentation; Female; Humans; Neuroleptic Malignant Syndrome; Piperazines; Psychotic Disorders; Quinolones	2008
Extreme elevation of creatinine phosphokinase levels in neuroleptic malignant syndrome associated with atypical antipsychotics. The American journal of psychiatry, 2009, Volume: 166, Issue:1 Topics: Adult; Antipsychotic Agents; Aripiprazole; Clozapine; Creatine Kinase; Dose-Response Relationship, Drug; Drug Interactions; Drug Therapy, Combination; Humans; Male; Myocardial Infarction; Neuroleptic Malignant Syndrome; Piperazines; Quinolones; Risperidone; Schizophrenia; Valproic Acid	2009
Neuroleptic malignant syndrome with the addition of aripiprazole to clozapine. Progress in neuro-psychopharmacology & biological psychiatry, 2010, Mar-17, Volume: 34, Issue:2 Topics: Adult; Antipsychotic Agents; Aripiprazole; Clozapine; Drug Synergism; Humans; Male; Neuroleptic Malignant Syndrome; Piperazines; Quinolones	2010
Functional SNPs in genes encoding the 5-HT2A receptor modify the affinity and potency of several atypical antipsychotic drugs. Biological research for nursing, 2011, Volume: 13, Issue:1 Topics: Antipsychotic Agents; Aripiprazole; Benzodiazepines; Clozapine; Dibenzothiazepines; Drug Resistance; HEK293 Cells; Humans; Mutagenesis, Site-Directed; Neuroleptic Malignant Syndrome; Nursing Research; Olanzapine; Pharmacogenetics; Piperazines; Polymorphism, Single Nucleotide; Quetiapine Fumarate; Quinolones; Receptor, Serotonin, 5-HT2A; Risperidone; Thiazoles	2011
Neuroleptic malignant syndrome secondary to aripiprazole initiation in a clozapine-intolerant patient. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2010, Volume: 67, Issue:15 Topics: Adult; Antipsychotic Agents; Aripiprazole; Clozapine; Female; Humans; Isoxazoles; Neuroleptic Malignant Syndrome; Paliperidone Palmitate; Piperazines; Pyrimidines; Quinolones; Schizophrenia	2010
Neuroleptic malignant syndrome with aripiprazole in Huntington's disease. Movement disorders : official journal of the Movement Disorder Society, 2010, Oct-30, Volume: 25, Issue:14 Topics: Antipsychotic Agents; Aripiprazole; Humans; Huntington Disease; Male; Middle Aged; Neuroleptic Malignant Syndrome; Piperazines; Quinolones	2010
Early detection and management of atypical neuroleptic malignant syndrome secondary to aripiprazole. Schizophrenia research, 2011, Volume: 132, Issue:1 Topics: Antipsychotic Agents; Aripiprazole; Humans; Male; Middle Aged; Neuroleptic Malignant Syndrome; Piperazines; Quinolones	2011
Aripiprazole-related severe neuroleptic malignant syndrome with deep coma and organic brain changes in an antipsychotic-naive adolescent boy. Journal of clinical psychopharmacology, 2013, Volume: 33, Issue:1 Topics: Adolescent; Antipsychotic Agents; Aripiprazole; Brain; Coma; Diagnosis, Differential; Humans; Male; Neuroleptic Malignant Syndrome; Piperazines; Predictive Value of Tests; Psychotic Disorders; Quinolones; Treatment Outcome	2013
Aripiprazole and neuroleptic malignant syndrome. International clinical psychopharmacology, 2004, Volume: 19, Issue:6 Topics: Adult; Antipsychotic Agents; Aripiprazole; Dose-Response Relationship, Drug; Humans; Lorazepam; Male; Neuroleptic Malignant Syndrome; Piperazines; Quinolones; Schizophrenia	2004
Aripiprazole and atypical neuroleptic malignant syndrome. Journal of the American Academy of Child and Adolescent Psychiatry, 2004, Volume: 43, Issue:12 Topics: Adolescent; Antipsychotic Agents; Aripiprazole; Humans; Male; Neuroleptic Malignant Syndrome; Piperazines; Quinolones; Time Factors	2004
Possible neuroleptic malignant syndrome with aripiprazole and fluoxetine. The American journal of psychiatry, 2005, Volume: 162, Issue:2 Topics: Adult; Antipsychotic Agents; Aripiprazole; Depressive Disorder; Drug Therapy, Combination; Fluoxetine; Humans; Male; Neuroleptic Malignant Syndrome; Piperazines; Quinolones; Selective Serotonin Reuptake Inhibitors	2005
Neuroleptic malignant syndrome and aripiprazole in an antipsychotic-naive patient. Journal of clinical psychopharmacology, 2006, Volume: 26, Issue:1 Topics: Adult; Antipsychotic Agents; Aripiprazole; Female; Humans; Neuroleptic Malignant Syndrome; Piperazines; Quinolones	2006
Aripiprazole and the neuroleptic malignant syndrome. Schizophrenia research, 2006, Volume: 85, Issue:1-3 Topics: Antipsychotic Agents; Aripiprazole; Drug Administration Schedule; Humans; Neuroleptic Malignant Syndrome; Piperazines; Quinolones; Schizophrenia	2006
Neuroleptic malignant syndrome and aripiprazole. Journal of the American Academy of Child and Adolescent Psychiatry, 2006, Volume: 45, Issue:6 Topics: Adolescent; Anti-Anxiety Agents; Antipsychotic Agents; Aripiprazole; Depressive Disorder; Female; Humans; Intellectual Disability; Lorazepam; Neuroleptic Malignant Syndrome; Piperazines; Quinolones; United States	2006
Neuroleptic malignant syndrome with aripiprazole and lithium: a case report. Journal of clinical psychopharmacology, 2006, Volume: 26, Issue:4 Topics: Administration, Oral; Adult; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Humans; Lithium; Male; Neuroleptic Malignant Syndrome; Piperazines; Quinolones	2006
Advanced pediatric psychopharmacology. Journal of child and adolescent psychopharmacology, 2006, Volume: 16, Issue:4 Topics: Adolescent; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Cannabinoids; Combined Modality Therapy; Comorbidity; Drug Therapy, Combination; Humans; Male; Marijuana Abuse; Mental Status Schedule; Neuroleptic Malignant Syndrome; Patient Readmission; Piperazines; Prognosis; Psychoses, Substance-Induced; Quinolones; Recurrence; Social Environment; Thiazoles; Treatment Refusal	2006
Atypical neuroleptic malignant syndrome associated with aripiprazole. Journal of clinical psychopharmacology, 2006, Volume: 26, Issue:5 Topics: Adult; Antipsychotic Agents; Aripiprazole; Humans; Male; Neuroleptic Malignant Syndrome; Piperazines; Quinolones; Schizophrenia	2006
Aripiprazole and neuroleptic malignant syndrome. Journal of clinical psychopharmacology, 2007, Volume: 27, Issue:2 Topics: Adult; Antipsychotic Agents; Aripiprazole; Humans; Male; Neuroleptic Malignant Syndrome; Piperazines; Psychotic Disorders; Quinolones	2007
Neuroleptic malignant syndrome induced by low dose aripiprazole in first episode psychosis. Journal of psychiatric practice, 2007, Volume: 13, Issue:2 Topics: Acute Disease; Antipsychotic Agents; Aripiprazole; Diagnosis, Differential; Dose-Response Relationship, Drug; Female; Humans; Middle Aged; Neuroleptic Malignant Syndrome; Neurologic Examination; Piperazines; Psychotic Disorders; Quinolones	2007
Aripiprazole: malignant syndrome. Prescrire international, 2007, Volume: 16, Issue:91 Topics: Antipsychotic Agents; Australia; Humans; Neuroleptic Malignant Syndrome; Piperazines; Quinolones	2007